Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #73,551 to #73,600.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Mycobacterium smegmatis (8 revisions)
  2. Mycobacterium terrae (8 revisions)
  3. Mycoplasma (8 revisions)
  4. Mycoplasma pneumonia physical examination (8 revisions)
  5. Mycosis fungoides other diagnostic studies (8 revisions)
  6. Mycosis fungoides other imaging findings (8 revisions)
  7. Myelodysplastic syndrome electrocardiogram (8 revisions)
  8. Myelodysplastic syndrome primary prevention (8 revisions)
  9. Myelodysplastic syndrome screening (8 revisions)
  10. Myelofibrosis echocardiography or ultrasound (8 revisions)
  11. Myelofibrosis future or investigational therapies (8 revisions)
  12. Myeloproliferative neoplasm MRI (8 revisions)
  13. Myeloproliferative neoplasm chest x ray (8 revisions)
  14. Myocarditis x ray (8 revisions)
  15. Myoclonus overview (8 revisions)
  16. Myopia causes (8 revisions)
  17. Myopia surgery (8 revisions)
  18. Myxedema (8 revisions)
  19. Myxedema coma differential diagnosis (8 revisions)
  20. Myxedema coma physical examination (8 revisions)
  21. Naegleria infection natural history, complications and prognosis (8 revisions)
  22. Narcissism (psychology) (8 revisions)
  23. Nasopharyngeal carcinoma interventions (8 revisions)
  24. Nausea and Vomiting pathophysiology (8 revisions)
  25. Nausea and vomiting physical examination (8 revisions)
  26. Nausea and vomiting risk factors (8 revisions)
  27. Neomycin drug interactions (8 revisions)
  28. Neonatal jaundice epidemiology and demographics (8 revisions)
  29. Neonatal jaundice primary prevention (8 revisions)
  30. Neonatal jaundice ultrasound (8 revisions)
  31. Neoplastic meningitis MRI (8 revisions)
  32. Neoplastic meningitis historical perspective (8 revisions)
  33. Nephritis (8 revisions)
  34. Nephrotic syndrome historical perspective (8 revisions)
  35. Nerve palsy (8 revisions)
  36. Neurocardiogenic syncope pacemaker therapy (8 revisions)
  37. Neuroendocrine tumors other imaging findings (8 revisions)
  38. Neurofibroma risk factors (8 revisions)
  39. Neurofibromatosis type 1 natural history, complications and prognosis (8 revisions)
  40. Neurofibromatosis type 1 physical examination (8 revisions)
  41. Neurogenic bladder (8 revisions)
  42. Neurology (8 revisions)
  43. Neuromuscular-blocking drugs (8 revisions)
  44. Neurosyphilis (patient information) (8 revisions)
  45. Neurosyphilis MRI (8 revisions)
  46. Neurosyphilis secondary prevention (8 revisions)
  47. Neutropenia epidemiology and demographics (8 revisions)
  48. Neutropenia historical perspective (8 revisions)
  49. Niacin extended release (8 revisions)
  50. Night eating syndrome (8 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)